|
|
|
|
|
|
 |
|
Research Finds Tumor
Preventive Qualities, Damage Reversal, in Green Tea Behind the Cancer Headlines® Drinking green tea may do more than just thwart a head cold, according to research presented at the American Association for Cancer Research Second Annual International Conference on Frontiers in Cancer Prevention Research. Green tea already is believed to help lower cholesterol and prevent heart disease, fight bacteria and dental cavities, and possibly aid weight loss. New studies are now suggesting the various potential anti-cancer benefits of the age-old beverage. "Laboratory studies have suggested that green tea consumption may produce many health benefits, including the prevention of cancer, but the beneficial effects in humans are not clearly known," said C.S. Yang, Ph.D., of Rutgers University, N.J. "Research is now showing how this novel chemopreventive agent might work at the molecular level and in the human population," he added. EGCG (epigallocatchin-3-gallate) is the most abundant and active chemopreventive agent in green tea, and has been associated with reduced risk of breast, pancreatic, colon, esophageal and lung cancers in humans. However, EGCG has a low oral bioavailability, meaning that to sustain effective levels for biological activity, individuals would need to drink at least seven to eight cups of tea a day, or ingest large amounts of green tea polyphenol extract. As a first stop toward overcoming this problem, researchers
from SRI International in
"These analogs are not only valuable tools to clarify how green tea may fight cancer, but are also potential chemopreventive drug candidates themselves, with perhaps better pharmacokinetic properties than have been seen with EGCG thus far," said SRI's Nurulain Zaveri, Ph.D., lead author of the study. SOURCES: Second Annual International Conference on Frontiers in Cancer
Prevention Research,
American Association for Cancer Research (http://www.aacr.org) DISCLAIMER!Behind the Cancer Headlines (TM) is a service of Willis-Knighton Cancer Center.The articles in Behind the Cancer Headlines (TM) are written by national medical editorsand writers who review current literature and develop timely articles in non-technicallanguage. Sources of information are cited for each article. If you have questions, referto the sources listed or to your physician. Willis-Knighton Cancer Center is notresponsible for content. Articles are updated on Monday, Wednesday, and Friday. This information is provided for information only and is not a substitute for informationfrom or care by a physician. |
|
If you have comments, questions or problems with this website, please contact: webmaster@wkhs.com Willis-Knighton Health System. All rights reserved. |
|
| Home | Staff | Equipment | Patient Info | Links/Clinical Trials | Treatments | News Articles | Directions/Map | Center for IMRT |